Table 8.
Logistic regression analysis for risk factors of OMG patients combined with TAO
| Variable | B | S.E.M. | Wald | df | Sig. | Exp (B) | 95% CI |
|---|---|---|---|---|---|---|---|
| AchRAb | –0.295 | 0.671 | 0.193 | 1 | 0.661 | 0.745 | 0.200–2.775 |
| T-Ab | 1.325 | 0.665 | 3.966 | 1 | 0.046 | 3.762 | 1.021–13.863 |
| DQA1*0103 | 0.769 | 0.786 | 0.958 | 1 | 0.328 | 2.158 | 0.462–10.65 |
| DQA1*0301 | 0.756 | 0.401 | 3.561 | 1 | 0.059 | 2.131 | 0.971–4.674 |
| DQB1*0501 | 0.780 | 0.423 | 3.401 | 1 | 0.065 | 2.180 | 0.952–4.993 |
| DQB1*0601 | –0.977 | 1.222 | 0.638 | 1 | 0.424 | 0.377 | 0.034–4.133 |
| TNF-α -863C > A | 1.276 | 0.418 | 9.304 | 1 | 0.002 | 3.584 | 4.578–8.139 |
| TNF-α -238G > A | –0.379 | 0.558 | 0.463 | 1 | 0.496 | 0.684 | 0.229–2.042 |
| TNF-α -308G > A | 0.120 | 0.481 | 0.062 | 1 | 0.803 | 1.127 | 0.439–2.892 |
B, partial regression coefficient; df, degree of freedom; Exp (B), adjusted OR; Sig., significant P value; Wald, Wald χ2.